Cargando…

In systemic sclerosis patients the anxiety disorder and Raynaud’s phenomenon are increased during lock down period for COVID-19 pandemic

Detalles Bibliográficos
Autores principales:	Gigante, Antonietta, Villa, Annalisa, Pellicano, Chiara, Rosato, Edoardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	CE-Research Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656092/ https://www.ncbi.nlm.nih.gov/pubmed/33175296 http://dx.doi.org/10.1007/s11739-020-02557-z

Ejemplares similares

Symptoms related to gastrointestinal tract involvement and low muscularity in systemic sclerosis
por: Rosato, Edoardo, et al.
Publicado: (2022)

Audiovestibular Manifestations in Patients with Primary Raynaud’s Phenomenon and Raynaud’s Phenomenon Secondary to Systemic Sclerosis
por: Amor-Dorado, Juan Carlos, et al.
Publicado: (2023)

Raynaud’s Phenomenon with Focus on Systemic Sclerosis
por: Maciejewska, Magdalena, et al.
Publicado: (2022)

Raynaud’s phenomenon
por: Solomons, HD
Publicado: (2011)

Raynaud's Phenomenon
por: Shah, Jehan, et al.
Publicado: (2013)

Serum resistin is predictive marker of development of new digital ulcers in systemic sclerosis
por: Pellicano, Chiara, et al.
Publicado: (2021)

Hyperspectral imaging in systemic sclerosis-associated Raynaud phenomenon
por: Teaw, Shannon, et al.
Publicado: (2023)

Advances in the treatment of Raynaud’s phenomenon
por: Levien, Terri L
Publicado: (2010)

Raynaud's phenomenon in pediatric age
por: Tavares, M, et al.
Publicado: (2011)

Raynaud's Phenomenon: Beware of Cancers!
por: Aqodad, Zahida, et al.
Publicado: (2021)

Solvent-Induced Raynaud’s Phenomenon
por: Rodrigues, Helena, et al.
Publicado: (2023)

Patient Perspective, Complexities, and Challenges in Managed Care
por: Jan, Saira
Publicado: (2010)

Atrial Fibrillation and Managed Care: Current Approaches and Future Directions for Long-Term Therapy
por: Sanoski, Cynthia A., et al.
Publicado: (2009)

Reduced levels of S-nitrosothiols in plasma of patients with systemic sclerosis and Raynaud's phenomenon
por: Kundu, Devi, et al.
Publicado: (2014)

CD21(low) B cells are predictive markers of new digital ulcers in systemic sclerosis
por: Visentini, Marcella, et al.
Publicado: (2021)

Recent achievements in the management of Raynaud’s phenomenon
por: Baumhäkel, Magnus, et al.
Publicado: (2010)

Glomus Tumor Presenting as Raynaud's Phenomenon
por: Abdelrahman, M. H., et al.
Publicado: (2012)

Monostotic fibrous dysplasia with Raynaud's phenomenon
por: Kumar, K. V. S. Hari, et al.
Publicado: (2015)

Systemic lupus erythematosus and Raynaud's phenomenon
por: Heimovski, Flavia Emilie, et al.
Publicado: (2015)

Pacinian hyperplasia presenting with Raynaud’s phenomenon
por: Pickrell, Brent B., et al.
Publicado: (2019)

Prevalence of Raynaud’s Phenomenon in Saudi Arabia
por: Mustafa, Mohammad, et al.
Publicado: (2022)

Lower limb ulcer and Raynaud's phenomenon
por: Chérif, Mohammad Yassine, et al.
Publicado: (2022)

Raynaud’s Phenomenon: A Brush Up!
por: Swarnkar, Bhavya, et al.
Publicado: (2023)

A violist with asymmetrical Raynaud’s phenomenon
por: Silva, Beatriz C, et al.
Publicado: (2023)

Endothelin Receptor Antagonists for the Treatment of Raynaud's Phenomenon and Digital Ulcers in Systemic Sclerosis
por: Arefiev, Kait, et al.
Publicado: (2011)

Rheopheresis for Digital Ulcers and Raynaud's Phenomenon in Systemic Sclerosis Refractory to Conventional Treatments
por: Korsten, Peter, et al.
Publicado: (2019)

Microbiome, Autoimmune Diseases and HIV Infection: Friends or Foes?
por: Pellicano, Chiara, et al.
Publicado: (2019)

Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis
por: Leodori, Giorgia, et al.
Publicado: (2022)

Digital Thermography of the Fingers and Toes in Raynaud's Phenomenon
por: Lim, Mie Jin, et al.
Publicado: (2014)

Risperidone Related Raynaud’s Phenomenon: An Adolescent Case
por: Güneş, Serkan, et al.
Publicado: (2018)

Innovations in the Assessment of Primary and Secondary Raynaud’s Phenomenon
por: Ruaro, Barbara, et al.
Publicado: (2019)

Raynaud’s Phenomenon: Reviewing the Pathophysiology and Management Strategies
por: Nawaz, Iqra, et al.
Publicado: (2022)

Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud’s phenomenon
por: Park, Jin-Su, et al.
Publicado: (2015)

Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022)

Artifactual Hypoglycaemia in Systemic Sclerosis and Raynaud's Phenomenon: A Clinical Case Report and Short Review
por: Bishay, RH, et al.
Publicado: (2016)

Association between systemic sclerosis, palmar fasciitis with polyarthritis, Raynaud’s phenomenon and erythromelalgia with underlying malignancy
por: Nowak, Katarzyna, et al.
Publicado: (2022)

Local hyperhemia to heating is impaired in secondary Raynaud's phenomenon
por: Boignard, Aude, et al.
Publicado: (2005)

Finger pad tophi in a patient with Raynaud phenomenon
por: Zarbafian, Misha, et al.
Publicado: (2017)

Raynaud’s Phenomenon: A Brief Review of the Underlying Mechanisms
por: Fardoun, Manal M., et al.
Publicado: (2016)

A serious case of primary Raynaud's phenomenon in an infant
por: Kobayashi, Masaru, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qr197ugru3pvgfthbfjd8f1dhl